These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17885853

  • 1. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
    Kim K, Quesada J, Szmaydy-Rikken N, Darken P, Shah T.
    J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
    [Abstract] [Full Text] [Related]

  • 2. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis.
    Ratner P, Darken P, Wingertzahn M, Shah T.
    J Asthma; 2007 Oct; 44(8):629-33. PubMed ID: 17943573
    [Abstract] [Full Text] [Related]

  • 3. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
    Derom E, Louis R, Tiesler C, Engelstätter R, Kaufman JM, Joos GF.
    Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J, Nave R, Lahu G, Derom E, Derendorf H.
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis.
    Chervinsky P, Kunjibettu S, Miller DL, Prenner BM, Raphael G, Hall N, Shah T.
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):69-76. PubMed ID: 17650833
    [Abstract] [Full Text] [Related]

  • 6. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
    Pulm Pharmacol Ther; 2005 Jul; 18(5):328-36. PubMed ID: 15939311
    [Abstract] [Full Text] [Related]

  • 7. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Jul; 21(2):264-75. PubMed ID: 17604664
    [Abstract] [Full Text] [Related]

  • 8. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
    Magnussen H, Hofman J, Staneta P, Lawo JP, Hellwig M, Engelstätter R.
    J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.
    Korn S, Buhl R.
    Respir Med; 2012 Jan; 106(1):57-67. PubMed ID: 21890335
    [Abstract] [Full Text] [Related]

  • 10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 11. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
    Webb DR, Meltzer EO, Finn AF, Rickard KA, Pepsin PJ, Westlund R, Cook CK.
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):385-90. PubMed ID: 11995670
    [Abstract] [Full Text] [Related]

  • 12. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 13. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
    Rosenblut A, Bardin PG, Muller B, Faris MA, Wu WW, Caldwell MF, Fokkens WJ.
    Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
    [Abstract] [Full Text] [Related]

  • 14. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
    Vargas R, Dockhorn RJ, Findlay SR, Korenblat PE, Field EA, Kral KM.
    J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
    [Abstract] [Full Text] [Related]

  • 15. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 16. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
    Patel D, Ratner P, Clements D, Wu W, Faris M, Philpot E.
    Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
    [Abstract] [Full Text] [Related]

  • 17. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H, Wingertzahn MA.
    Allergy Asthma Proc; 2010 May; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [Abstract] [Full Text] [Related]

  • 18. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE.
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [Abstract] [Full Text] [Related]

  • 19. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 20. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.